Increased plasma norepinephrine levels in previously pre-eclamptic women

Journal of Human Hypertension

Volumn 28, Issue 4, 2014, Pages 269-273

  Lampinen, K H ^a,b,c   Ronnback M ^a,b   Groop, P H ^a,b   Nicholls, M G ^d   Yandle, T G ^d   Kaaja, R J ^e  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b FOLKHÄLSAN RESEARCH CENTER   (Finland)

^c Department of Obstetrics and Gynecology ^*  (Sweden)

^d UNIVERSITY OF OTAGO   (New Zealand)

^e UNIVERSITY OF TURKU   (Finland)

Author keywords

cardiovascular risk; catecholamines; hypertension; pre eclampsia; sympathetic nervous system

Indexed keywords

ENDOTHELIN 1; NORADRENALIN; BIOLOGICAL MARKER;

ADULT; ARTERIAL PRESSURE; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR FUNCTION; CLINICAL ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; HEART RATE; HUMAN; INSULIN SENSITIVITY; NORADRENALIN BLOOD LEVEL; PATHOPHYSIOLOGY; PREECLAMPSIA; PROTEIN BLOOD LEVEL; PULSE WAVE; REST; STANDING; SUPINE POSITION; SYSTOLIC BLOOD PRESSURE; VASODILATATION; VEIN OCCLUSION PLETHYSMOGRAPHY; ADRENERGIC SYSTEM; BLOOD; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; CASE CONTROL STUDY; COMPLICATION; HYPERTENSION; INSULIN RESISTANCE; PHYSIOLOGY; PREGNANCY; PUERPERIUM; RISK FACTOR; TIME;

ADULT; BIOLOGICAL MARKERS; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; ENDOTHELIN-1; FEMALE; HEART RATE; HUMANS; HYPERTENSION; INSULIN RESISTANCE; NOREPINEPHRINE; POSTPARTUM PERIOD; PRE-ECLAMPSIA; PREGNANCY; RISK FACTORS; SYMPATHETIC NERVOUS SYSTEM; TIME FACTORS;

EID: 84896319128     PISSN: 09509240     EISSN: 14765527     Source Type: Journal    
DOI: 10.1038/jhh.2013.84     Document Type: Article

References (44)

1. High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Report of the national high blood pressure education program working group on high blood pressure in pregnancy. Am J Obstet Gynecol 2000; 183: S1-S22.
2. Kaaja R. Insulin resistance syndrome in preeclampsia. Semin Reprod Endocrinol 1998; 16: 41-46.
3. Lorentzen B, Henriksen T. Plasma lipids and vascular dysfunction in preeclampsia. Semin Reprod Endocrinol 1998; 16: 33-39.
4. Roberts JM. Endothelial dysfunction in preeclampsia. Semin Reprod Endocrinol 1998; 16: 5-15.
5. Bellamy L, Casas JP, Hingorani AD, Williams DJ. Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis. BMJ 2007; 335: 974.
6. Hannaford P, Ferry S, Hirsch S. Cardiovascular sequelae of toxaemia of pregnancy. Heart 1997; 77: 154-158.
7. Irgens HU, Reisaeter L, Irgens LM, Lie RT. Long term mortality of mothers and fathers after pre-eclampsia: population based cohort study. BMJ 2001; 323: 1213-1217.
8. Smith GC, Pell JP, Walsh D. Pregnancy complications and maternal risk of ischaemic heart disease: a retrospective cohort study of 129, 290 births. Lancet 2001; 357: 2002-2006.
9. Wilson BJ, Watson MS, Prescott GJ, Sunderland S, Campbell DM, Hannaford P et al. Hypertensive diseases of pregnancy and risk of hypertension and stroke in later life: results from cohort study. BMJ 2003; 326: 845.
10. Männistö T, Mendola P, Vääräsmäki M, Järvelin M-R, Hartikainen A-L, Pouta A et al. Elevated blood pressure in pregnancy and subsequent chronic disease risk. Circulation 2013; 127: 681-690.
11. Greenwood JP, Scott EM, Stoker JB, Walker JJ, Mary DA. Sympathetic neural mechanisms in normal and hypertensive pregnancy in humans. Circulation 2001; 104: 2200-2204.
12. Greenwood JP, Stoker JB, Walker JJ, Mary DA. Sympathetic nerve discharge in normal pregnancy and pregnancy-induced hypertension. J Hypertens 1998; 16: 617-624.
13. Kaaja RJ, Moore MP, Yandle TG, Ylikorkala O, Frampton CM, Nicholls MG. Blood pressure and vasoactive hormones in mild preeclampsia and normal pregnancy. Hypertens Pregnancy 1999; 18: 173-187.
14. Schobel HP, Fischer T, Heuszer K, Geiger H, Schmieder RE. Preeclampsia-a state of sympathetic overactivity. N Engl J Med 1996; 335: 1480-1485.
15. Courtar DA, Spaanderman ME, Aardenburg R, Janssen BJ, Peeters LL. Low plasma volume coincides with sympathetic hyperactivity and reduced baroreflex sensitivity in formerly preeclamptic patients. J Soc Gynecol Investig 2006; 13: 48-52.
16. Collen A-C, Hellgren M, Gustafsson H, Johansson MC, Manhem K. Cardiovascular and metabolic characteristics 40 years after hypertensive pregnancies: a long-term follow-up study of mothers. J Hypertens 2013; 30: 1-8.
17. Esler M. Sympathetic nervous system: contribution to human hypertension and related cardiovascular diseases. J Cardiovasc Pharmacol 1995; 26(Suppl 2): S24-S28.
18. Julius S, Jamerson K. Sympathetics, insulin resistance and coronary risk in hypertension: the 'chicken-and-egg' question. J Hypertens 1994; 12: 495-502.
19. Pauletto P, Scannapieco G, Pessina AC. Sympathetic drive and vascular damage in hypertension and atherosclerosis. Hypertension 1991; 17: III75-III81.
20. Egan BM. Insulin resistance and the sympathetic nervous system. Curr Hypertens Rep 2003; 5: 247-254.
21. Julius S. Abnormalities of autonomic nervous control in human hypertension. Cardiovasc Drugs Ther 1994; 8(Suppl 1): 11-20.
22. Kjeldsen SE, Westheim A, Aakesson I, Eide I, Leren P. Plasma adrenaline and noradrenaline during orthostasis in man: the importance of arterial sampling. Scand J Clin Lab Invest 1986; 46: 397-401.
23. Mancia G, Bousquet P, Elghozi JL, Esler M, Grassi G, Julius S et al. The sympathetic nervous system and the metabolic syndrome. J Hypertens 2007; 25: 909-920.
24. George EM, Granger JP. Endothelin: key mediator of hypertension in pre-eclampsia. Am J Hypertens 2011; 24: 964-969, Review.
25. Bruno RM, Sudano I, Ghiadoni L, Masi L, Taddei S. Interactions between sympathetic nervous system and endogenous endothelin in patients with essential hypertension. Hypertension 2011; 57: 79-84.
26. ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Number 33, January 2002. Obstet Gynecol 2002; 99: 159-167.
27. Lampinen KH, Ronnback M, Kaaja RJ, Groop PH. Impaired vascular dilatation in women with a history of pre-eclampsia. J Hypertens 2006; 24: 751-756.
28. Eisenhofer G, Goldstein DS, Stull R, Keiser HR, Sunderland T, Murphy DL et al. Simultaneous liquid-chromatographic determination of 3, 4-dihydroxyphenylglycol, catecholamines, and 3, 4-dihydroxyphenylalanine in plasma, and their responses to inhibition of monoamine oxidase. Clin Chem 1986; 32: 2030-2033.
29. Boston RC, Stefanovski D, Moate PJ, Sumner AE, Watanabe RM, Bergman RN. MINMOD Millennium: a computer program to calculate glucose effectiveness and insulin sensitivity from the frequently sampled intravenous glucose tolerance test. Diabetes Technol Ther 2003; 5: 1003-1015.
30. Lampinen KH, Ronnback M, Groop PH, Kaaja RJ. A relationship between insulin sensitivity and vasodilation in women with a history of preeclamptic pregnancy. Hypertension 2008; 52: 394-401.
31. Haukkamaa L, Salminen M, Laivuori H, Leinonen H, Hiilesmaa V, Kaaja R. Risk for subsequent coronary artery disease after preeclampsia. Am J Cardiol 2004; 93: 805-808.
32. Nisell H, Lintu H, Lunell NO, Mollerstrom G, Pettersson E. Blood pressure and renal function seven years after pregnancy complicated by hypertension. Br J Obstet Gynaecol 1995; 102: 876-881.
33. Pouta A, Hartikainen AL, Sovio U, Gissler M, Laitinen J, McCarthy MI et al. Manifestations of metabolic syndrome after hypertensive pregnancy. Hypertension 2004; 43: 825-831.
34. Hjemdahl P. Plasma catecholamines-analytical challenges and physiological limitations. Baillieres Clin Endocrinol Metab 1993; 7: 307-353.
35. Grassi G, Esler M. How to assess sympathetic activity in humans. J Hypertens 1999; 17: 719-734.
36. Flaa A, Aksnes TA, Kjeldsen SE, Eide I, Rostrup M. Increased sympathetic reactivity may predict insulin resistance: an 18-year follow-up study. Metabolism 2008; 57: 1422-1427.
37. Masuo K, Mikami H, Ogihara T, Tuck ML. Sympathetic nerve hyperactivity precedes hyperinsulinemia and blood pressure elevation in a young, nonobese Japanese population. Am J Hypertens 1997; 10: 77-83.
38. Hasking GJ, Esler MD, Jennings GL, Burton D, Johns JA, Korner PI. Norepinephrine spillover to plasma in patients with congestive heart failure: evidence of increased overall and cardiorenal sympathetic nervous activity. Circulation 1986; 73: 615-621.
39. Fischer T, Schobel HP, Frank H, Andreae M, Schneider KT, Heusser K. Pregnancy-induced sympathetic overactivity: a precursor of preeclampsia. Eur J Clin Invest 2004; 34: 443-448.
40. Stein CM, Nelson R, Deegan R, He H, Wood M, Wood AJ. Forearm beta adrenergic receptor-mediated vasodilation is impaired, without alteration of forearm norepinephrine spillover, in borderline hypertension. J Clin Invest 1995; 96: 579-585.
41. Chambers JC, Fusi L, Malik IS, Haskard DO, De Swiet M, Kooner JS. Association of maternal endothelial dysfunction with preeclampsia. JAMA 2001; 285: 1607-1612.
42. Touyz RM. Schiffrin EL.Role of endothelin in human hypertension. Can J Physiol Pharmacol 2003; 81: 533-541, Review.
43. Esler MD, Hasking GJ, Willett IR, Leonard PW, Jennings GL. Noradrenaline release and sympathetic nervous system activity. J Hypertens 1985; 3: 117-129.
44. Bergman RN, Prager R, Volund A, Olefsky JM. Equivalence of the insulin sensitivity index in man derived by the minimal model method and the euglycemic glucose clamp. J Clin Invest 1987; 79: 790-800.